Toufic Finge1, Sébastien Bertran, Claire Roger, Damien Candela, Bruno Pereira, Christopher Scott, Laurent Muller, Benjamin Louart, Jean-Yves Lefrant. 1. From the *Service of Anesthesia and Intensive Care, Hôpital Privé Les Franciscaines, 3 Rue Jean Bouin 30032 NÎMES Cedex 1, France; †Division of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes University Hospital, Place du Professeur Robert Debré, 30 029 Nîmes Cedex 9, France; and ‡Department of Clinical Research and Innovation (DRCI), Clermont-Ferrand, France.
Abstract
BACKGROUND: This study assessed the ability of 3-hour postoperative urinary tissue inhibitor of metalloproteinases-2 × insulin-like growth factor binding protein-7 ([TIMP-2] × [IGFBP-7]) to predict postoperative acute kidney injury (AKI) in patients undergoing cardiopulmonary bypass during cardiac surgery. METHODS: Patients undergoing cardiac surgery with cardiopulmonary bypass were eligible for this study. Patients with initial chronic renal insufficiency requiring renal replacement therapy, patients <18 years of age, and parturients were not included. Anesthesia and hemodynamic management followed current practices. Urinary [TIMP2] × [IGFBP-7] was measured in 3-hour postoperative period. The primary objective was the occurrence of AKI (Kidney Disease: Improving Global Outcome [KDIGO] stage >0) within the first 48 hours postoperatively. The ability of urinary [TIMP-2] × [IGFBP-7] to predict postoperative AKI was assessed by building a receiver operating characteristic curve (with 95% confidence interval [CI] and by a gray zone approach that allowed either the prediction or the exclusion of postoperative AKI with a sensitivity >0.90 and a specificity >0.90). RESULTS: AKI occurred in 34 of 93 patients included (37%). The area under the receiver operating characteristic curve of urinary [TIMP-2] × [IGFBP-7] was 0.73 (95% CI, 0.62-0.83). The best cutoff value for urinary [TIMP-2] × [IGFBP-7] in predicting AKI was 0.3 ng/mL/1000 [0.09-1.40] (sensitivity = 76%; 95% CI, 73-97, specificity = 64%; 95% CI, 42-69). Urinary [TIMP-2] × [IGFBP-7] of <0.09 ng/mL/1000 and >1.40 ng/mL/1000 had a sensitivity and specificity >90% in predicting postoperative AKI. Fifty-nine patients (63%) were within the gray zone. CONCLUSIONS: In patients undergoing cardiopulmonary bypass during cardiac surgery, urinary [TIMP-2] × [IGFBP-7] could not accurately predict the occurrence of postoperative AKI.
BACKGROUND: This study assessed the ability of 3-hour postoperative urinary tissue inhibitor of metalloproteinases-2 × insulin-like growth factor binding protein-7 ([TIMP-2] × [IGFBP-7]) to predict postoperative acute kidney injury (AKI) in patients undergoing cardiopulmonary bypass during cardiac surgery. METHODS:Patients undergoing cardiac surgery with cardiopulmonary bypass were eligible for this study. Patients with initial chronic renal insufficiency requiring renal replacement therapy, patients <18 years of age, and parturients were not included. Anesthesia and hemodynamic management followed current practices. Urinary [TIMP2] × [IGFBP-7] was measured in 3-hour postoperative period. The primary objective was the occurrence of AKI (Kidney Disease: Improving Global Outcome [KDIGO] stage >0) within the first 48 hours postoperatively. The ability of urinary [TIMP-2] × [IGFBP-7] to predict postoperative AKI was assessed by building a receiver operating characteristic curve (with 95% confidence interval [CI] and by a gray zone approach that allowed either the prediction or the exclusion of postoperative AKI with a sensitivity >0.90 and a specificity >0.90). RESULTS: AKI occurred in 34 of 93 patients included (37%). The area under the receiver operating characteristic curve of urinary [TIMP-2] × [IGFBP-7] was 0.73 (95% CI, 0.62-0.83). The best cutoff value for urinary [TIMP-2] × [IGFBP-7] in predicting AKI was 0.3 ng/mL/1000 [0.09-1.40] (sensitivity = 76%; 95% CI, 73-97, specificity = 64%; 95% CI, 42-69). Urinary [TIMP-2] × [IGFBP-7] of <0.09 ng/mL/1000 and >1.40 ng/mL/1000 had a sensitivity and specificity >90% in predicting postoperative AKI. Fifty-nine patients (63%) were within the gray zone. CONCLUSIONS: In patients undergoing cardiopulmonary bypass during cardiac surgery, urinary [TIMP-2] × [IGFBP-7] could not accurately predict the occurrence of postoperative AKI.
Authors: Natalie A Silverton; Isaac E Hall; Natalia P Melendez; Brad Harris; Jackson S Harley; Samuel R Parry; Lars R Lofgren; Gregory J Stoddard; Guillaume L Hoareau; Kai Kuck Journal: J Cardiothorac Vasc Anesth Date: 2021-02-04 Impact factor: 2.894
Authors: Judith Schiefer; Paul Lichtenegger; Gabriela A Berlakovich; Walter Plöchl; Claus G Krenn; David M Baron; Joanna Baron-Stefaniak; Peter Faybik Journal: BMC Nephrol Date: 2019-07-17 Impact factor: 2.388
Authors: Kevin Esmeijer; Abraham Schoe; L Renee Ruhaak; Ellen K Hoogeveen; Darius Soonawala; Fred P H T M Romijn; Maryam R Shirzada; Jaap T van Dissel; Christa M Cobbaert; Johan W de Fijter Journal: Sci Rep Date: 2021-01-13 Impact factor: 4.379
Authors: Jan Waskowski; Carmen A Pfortmueller; Noelle Schenk; Roman Buehlmann; Juerg Schmidli; Gabor Erdoes; Joerg C Schefold Journal: PLoS One Date: 2021-01-07 Impact factor: 3.240
Authors: Nathan M Lee; Lev Deriy; Timothy R Petersen; Vallabh O Shah; Michael P Hutchens; Neal S Gerstein Journal: J Cardiothorac Vasc Anesth Date: 2018-08-01 Impact factor: 2.894